GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zivo Bioscience Inc (OTCPK:ZIVO) » Definitions » Cyclically Adjusted PB Ratio

ZIVO (Zivo Bioscience) Cyclically Adjusted PB Ratio : (As of Jun. 28, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Zivo Bioscience Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zivo Bioscience Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Zivo Bioscience's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zivo Bioscience Cyclically Adjusted PB Ratio Chart

Zivo Bioscience Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zivo Bioscience Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Zivo Bioscience's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Zivo Bioscience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zivo Bioscience's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zivo Bioscience's Cyclically Adjusted PB Ratio falls into.


;
;

Zivo Bioscience Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zivo Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Zivo Bioscience's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.427/134.9266*134.9266
=-0.427

Current CPI (Mar. 2025) = 134.9266.

Zivo Bioscience Quarterly Data

Book Value per Share CPI Adj_Book
201506 -29.136 100.684 -39.045
201509 -31.538 100.392 -42.387
201512 -35.437 99.792 -47.913
201603 -36.652 100.470 -49.222
201606 -40.126 101.688 -53.242
201609 -44.804 101.861 -59.348
201612 -47.793 101.863 -63.306
201703 -53.619 102.862 -70.333
201706 -57.141 103.349 -74.600
201709 -61.354 104.136 -79.495
201712 -55.456 104.011 -71.939
201803 -66.527 105.290 -85.253
201806 -56.401 106.317 -71.578
201809 -61.459 106.507 -77.859
201812 -59.419 105.998 -75.635
201903 -63.660 107.251 -80.088
201906 -15.673 108.070 -19.568
201909 -14.635 108.329 -18.228
201912 -10.082 108.420 -12.547
202003 -10.878 108.902 -13.478
202006 -11.798 108.767 -14.636
202009 -13.079 109.815 -16.070
202012 -13.152 109.897 -16.147
202103 -13.026 111.754 -15.727
202106 4.853 114.631 5.712
202109 4.727 115.734 5.511
202112 3.848 117.630 4.414
202203 2.920 121.301 3.248
202206 1.917 125.017 2.069
202209 0.971 125.227 1.046
202212 -0.007 125.222 -0.008
202303 -1.110 127.348 -1.176
202306 -2.003 128.729 -2.099
202309 -0.628 129.860 -0.653
202312 -0.926 129.419 -0.965
202403 -0.813 131.776 -0.832
202406 -0.692 132.554 -0.704
202409 -0.597 133.029 -0.606
202412 -0.142 133.157 -0.144
202503 -0.427 134.927 -0.427

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zivo Bioscience  (OTCPK:ZIVO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zivo Bioscience Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Zivo Bioscience's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zivo Bioscience Business Description

Traded in Other Exchanges
N/A
Address
2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084
Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's candidates are Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Companion Animal Food Ingredient, NDI (New Dietary Ingredient, and Skin Health.
Executives
Christopher D. Maggiore officer: CHIEF FINANCIAL OFFICER 4788 NOBLES POND DR. NW, CANTON OH 44718
Mark E Strome 10 percent owner 100 WILSHIRE BLVD, 15TH FL, SANTA MONICA CA 90401
John Bernard Payne director 9900 NE 114TH CIRCLE, VANCOUVER WA 98662
Alison A Cornell director 210 CARNEGIE CENTER, PRINCETON NJ 08540
Nola E Masterson director 768 WEST CALIFORNIA WAY, WOODSIDE CA 94062
Strome Mezzanine Fund, Lp 10 percent owner 100 WILSHIRE BLVD., SUITE 1750, SANTA MONICA CA 90401
Keith Marchiando officer: Chief Financial Officer C/O ZIVO BIOSCIENCE, INC., 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS MI 48304
Strome Alpha Fund L P 10 percent owner 100 WILSHIRE BLVD SUITE 1750, SANTA MONICA CA 90401
Strome Investment Management Lp 10 percent owner 100 WILSHIRE BLVD, 15TH FLOOR, SANTA MONICA CA 90401
Strome Group, Inc. 10 percent owner 100 WILSHIRE BLVD., SUITE 1750, SANTA MONICA CA 90401
Hep Investments Llc 10 percent owner 2804 ORCHARD LAKE RD, STE 205, KEEGO HARBOR MI 48320
Rondeau Robert O Jr director 70 WEST LONG LAKE RD, STE 119, TROY MI 48098
Thomas Kevin Cox director 470 MICHGAMME LANE, LAKE FOREST IL 60045
Andrew A Dahl officer: President, CEO 7 WEST SQUARE LAKE ROAD, STE 6165, BLOOMFIELD HILLS MI 48302
Brian W Young other: See remarks below. 1800 NW CORPORATE BLVD, BOCA RATON FL 33431